Cozad Asset Management Inc. Buys 1,046 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cozad Asset Management Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,755 shares of the healthcare conglomerate’s stock after acquiring an additional 1,046 shares during the period. UnitedHealth Group accounts for approximately 1.2% of Cozad Asset Management Inc.’s investment portfolio, making the stock its 17th biggest holding. Cozad Asset Management Inc.’s holdings in UnitedHealth Group were worth $12,442,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC raised its holdings in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares during the period. Finally, Soros Fund Management LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $39,413,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Raymond James Financial lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Truist Financial cut their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a research report on Wednesday, July 16th. Mizuho cut their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Finally, Baird R W lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $392.29.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $282.13 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a market cap of $255.93 billion, a price-to-earnings ratio of 11.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. The company has a 50-day moving average price of $300.91 and a 200-day moving average price of $422.56. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.13%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last quarter. 0.28% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.